Antibody Response to Hepatitis B Vaccine in End-Stage Renal Disease Patients

Publisher： Karger

E-ISSN： 1660-2110|103|3|c89-c93

ISSN： 1660-2110

Source： Nephron Clin Pract, Vol.103, Iss.3, 2006-03, pp. : c89-c93

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Improved Immunogenicity of a Novel Third-Generation Recombinant Hepatitis B Vaccine in Patients with End-Stage Renal Disease

By  

Nephron Clin Pract, Vol. 97, Iss. 2, 2004-11 ,pp. : c67-c72

Karger

Access to resources Recommend Favorite

Deferasirox in thalassemia patients with end‐stage renal disease

By  

AMERICAN JOURNAL OF HEMATOLOGY, Vol. 91, Iss. 10, 2016-10 ,pp. : E456-E457

John Wiley & Sons Inc

Access to resources Recommend Favorite

Treatment of Chronic Hepatitis C in Patients with End-Stage Renal Disease and Hemophilia – The Singapore Experience

By  

Intervirology, Vol. 49, Iss. 1-2, 2005-09 ,pp. : 107-111

Karger

Access to resources Recommend Favorite

Safety and efficacy of sofosbuvir‐based treatment of acute hepatitis C in end‐stage renal disease patients undergoing haemodialysis

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 47, Iss. 4, 2018-02 ,pp. : 526-532

John Wiley & Sons Inc

Access to resources Recommend Favorite

Response of Asymmetric Dimethylarginine to Hemodialysis-Associated Hypotension in End-Stage Renal Disease Patients

By  

Nephron Clin Pract, Vol. 108, Iss. 2, 2008-01 ,pp. : c127-c134

Karger

Access to resources Recommend Favorite